Mendelson W B
Department of Neurology, Cleveland Clinic Foundation, Ohio, USA.
Sleep. 1995 Feb;18(2):88-91. doi: 10.1093/sleep/18.2.88.
In previous studies we have reported that the benzodiazepine hypnotic triazolam and the nonbenzodiazepine zolpidem increase the likelihood that insomniacs will report having been asleep when awakened by an electronic tone of progressive intensity. It has not been known, however, whether this occurs with normal sleepers. In the present study we have administered placebo, flurazepam 30 mg and zolpidem 10 mg to 15 normal sleepers and awakened them with an electronic tone at five points across the night. In contrast to previous reports with insomniacs, both compounds made only modest improvements in sleep. When all time points were combined, subjects reported having been asleep in 40.3, 42.9 and 47.9% of the trials on placebo, flurazepam and zolpidem, respectively (ns). Subjects were accurate in their estimate of total time asleep, and this accuracy was not influenced by the drugs. Similarly, there were no effects on a variety of questions related to dreaming and other cognitive activity during sleep. These results suggest that the effects of these hypnotics, which have been described previously in insomniacs, are not found in normals. Further studies will be necessary to clarify whether such effects in insomniacs are related to the clinical efficacy of hypnotics.
在先前的研究中,我们报告过苯二氮䓬类催眠药三唑仑和非苯二氮䓬类药物唑吡坦会增加失眠者在被逐渐增强的电子音唤醒时报告自己已入睡的可能性。然而,尚不清楚正常睡眠者是否也会出现这种情况。在本研究中,我们给15名正常睡眠者服用了安慰剂、30毫克氟西泮和10毫克唑吡坦,并在夜间的五个时间点用电子音将他们唤醒。与先前关于失眠者的报告不同,这两种化合物对睡眠的改善都很有限。当把所有时间点的数据合并后,受试者在服用安慰剂、氟西泮和唑吡坦的试验中分别有40.3%、42.9%和47.9%的次数报告自己已入睡(无显著差异)。受试者对总睡眠时间的估计是准确的,而且这种准确性不受药物影响。同样,这些药物对与睡眠期间做梦及其他认知活动相关的各种问题也没有影响。这些结果表明,这些催眠药在失眠者身上所表现出的效果在正常睡眠者中并未出现。有必要进行进一步研究以阐明失眠者身上的这种效果是否与催眠药的临床疗效有关。